Navigation Links
The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Date:8/19/2007

l benefit response (CBR), time to progression (TTP), duration of response (DOR), progression-free survival, and best ORR throughout the study. Patients enrolled in the trial will receive carfilzomib twice weekly for three weeks every 28 days.

"Based on promising laboratory and clinical data, we believe that carfilzomib holds promise in treating patients with multiple myeloma, including those for whom other treatments have failed," said Sundar Jagannath, M.D., Saint Vincent's Comprehensive Cancer Center, where the first patient was enrolled. "We are excited to bring this compound into the MMRC as a critical step in bringing this new treatment to patients."

In the coming weeks, the MMRC and Proteolix will also begin enrolling an open-label, single-arm, Phase 2 study of carfilzomib in patients with relapsed multiple myeloma, who will be stratified by bortezomib (Velcade(R), Millennium Pharmaceuticals, Inc.) history.

About Carfilzomib

Carfilzomib is a structurally- and mechanistically-novel proteasome inhibitor that exhibits a high level of selectivity for the unique N-terminal threonine active sites within the proteasome. Carfilzomib is similar to bortezomib in that it is a potent inhibitor of the proteasome chymotrypsin- like activity, but unlike bortezomib, carfilzomib has shown minimal cross- reactivity with the other catalytic sites within the proteasome or across other protease classes. Phase 1 clinical studies confirmed that patients who have relapsed or progressed following multiple therapies can still achieve durable anti-tumor responses with carfilzomib. In addition to the two Phase 2 single-agent trials in myeloma and ongoing studies in lymphoma, a clinical trial in solid tumors and a trial exploring carfilzomib in combination with an FDA-approved agent will be initiated by the end of the year.

"The Phase 1 data consistently demonstrate carfilzomib anti-tumor activity in myeloma patients who have failed multiple lines of therapy,
'/>"/>

SOURCE Proteolix

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Gentiums Defibrotide Seen as Active in Multiple Myeloma
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
10. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
11. Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 Today, iHealth Lab Inc. announced it has ... for its first institutional round of funding. The strategic ... reach, accelerate growth and innovation, and invest in additional ... Xiaomi Ventures will join iHealth,s board of directors, bringing ... ecommerce. "We are very pleased to have ...
(Date:9/19/2014)... , September 19, 2014 ... has announced the addition of the ... to their offering.      (Logo: ... been broadly classified into wide categories based ... for the treatment of different gynecological conditions ...
(Date:9/19/2014)... Ill. , Sept. 19, 2014  The board ... ) declared a quarterly cash dividend of $0.42 per ... Nov. 17, 2014 to stockholders of record at the ... About AbbVie AbbVie is a global, research-based biopharmaceutical company ... mission is to use its expertise, dedicated people and ...
Breaking Medicine Technology:iHealth Raises $25 Million to Fuel Growth and Global Market Share 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3
... 2011 Reportlinker.com announces that a new market ... Global Microscopes Industry ... the worldwide markets for Microscopes in US$ Million ... Microscopes, and Scanning Probe Microscopes. The report also ...
... StemCyte, Inc. announces the launch of www.cordbloodtv.com , ... offers this comprehensive educational tool that allows audiences worldwide ... blood banking options and the latest in medical research ... "StemCyte is pleased to offer our worldwide ...
Cached Medicine Technology:Reportlinker Adds Global Microscopes Industry 2Reportlinker Adds Global Microscopes Industry 3Reportlinker Adds Global Microscopes Industry 4Reportlinker Adds Global Microscopes Industry 5Reportlinker Adds Global Microscopes Industry 6Reportlinker Adds Global Microscopes Industry 7Reportlinker Adds Global Microscopes Industry 8Reportlinker Adds Global Microscopes Industry 9Reportlinker Adds Global Microscopes Industry 10Reportlinker Adds Global Microscopes Industry 11Reportlinker Adds Global Microscopes Industry 12Reportlinker Adds Global Microscopes Industry 13Reportlinker Adds Global Microscopes Industry 14Reportlinker Adds Global Microscopes Industry 15Reportlinker Adds Global Microscopes Industry 16Reportlinker Adds Global Microscopes Industry 17Reportlinker Adds Global Microscopes Industry 18Reportlinker Adds Global Microscopes Industry 19Reportlinker Adds Global Microscopes Industry 20Reportlinker Adds Global Microscopes Industry 21Reportlinker Adds Global Microscopes Industry 22StemCyte Launches CordBloodTV 2
(Date:9/20/2014)... 20, 2014 The print component ... edition of the Calgary Herald, with a circulation ... of 270,000. The digital component is distributed nationally ... a network of top news sites and partner ... campaign, visit http://www.worklifebalanceinfo.ca . , The publication ...
(Date:9/20/2014)... NY (PRWEB) September 20, 2014 Ticket ... Grande concert tickets for her 2015 “Honeymoon Tour.” ... code ARIANA-2015 for added savings. , In early 2015, fans ... stars in the world across North America. Twenty-one-year-old Ariana Grande ... Tour,” which will take her to 25 cities across the ...
(Date:9/20/2014)... The excitement is building up once again for ... This year the Surry Arts Council will be celebrating its ... country who are still fans of the Andy Griffith Show. ... aired on CBS from 1960 through 1968. The show ranked ... history. Mount Airy, North Carolina is where the show was ...
(Date:9/20/2014)... York, NY (PRWEB) September 20, 2014 Earlier ... of their customers may have had their credit card information ... last year, spawning a slew of headline articles like ... those weren’t the only eye opening numbers. , “Most ... were stolen, almost like it’s a way to score a ...
(Date:9/20/2014)... The first federal bellwether trial of ... third week in the U.S. District Court, Northern District ... indicate that the week opened in the DePuy ... DePuy Orthopaedics vice president, who discussed the clinical testing ... hip replacement. According to Reuters, the executive stated that ...
Breaking Medicine News(10 mins):Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Mayberry Days Parade Cars will be Provided by Mount Airy Toyota and Mount Airy Chrysler Dodge Jeep Ram 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4
... to control behavior seems to be part of the ,culture, ... (HealthDay News) -- Many Americans in nursing homes still get ... to rein in the practice, two new studies show. , ... physical health. Since the U.S. Food and Drug Administration instituted ...
... , , , , ... Baby Einstein, has filed an open-records complaint in Washington state court ... to release records relating to two studies that examined the effects ... has been pursuing release of the experimental methods, raw data and ...
... , , FAIRVIEW, Pa., Jan. ... designer and manufacturer of custom electronic products and systems, today reported ... 2009. , For the fourth quarter of fiscal 2009, the ... share on sales of $34.1 million, compared to net income of ...
... from heart disease, researchers say, , MONDAY, Jan. 11 (HealthDay ... increase your risk of an early death from cardiovascular disease ... What,s on the television is not the problem; it,s the ... clear link between too much sitting and death from disease," ...
... Texas, Jan. 11 OrthoSynetics(TM), the ... today announced that it has partnered with the leading ... of these two industry leaders provides the ultimate practice ... some of the most successful and profitable orthodontic practices ...
... , , , , PHILADELPHIA, Jan. 11 ... more than $566,000 in a state-of-the-art inventory management system ... of stock accuracy and the Penn Customer Portal. This ... in its class in the U.S. or Europe to ...
Cached Medicine News:Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 2Health News:Antipsychotics Still Widely Used in U.S. Nursing Homes 3Health News:Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research 2Health News:Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research 3Health News:Co-Founder of Baby Einstein Files Open-Records Complaint for Access to University of Washington Research 4Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 2Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 3Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 4Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 5Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 6Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 7Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 8Health News:Spectrum Control Reports Fourth Quarter and Annual Profit 9Health News:TV Watching May Shorten Your Life 2Health News:TV Watching May Shorten Your Life 3Health News:OrthoSynetics(TM) Adds ORTHOTRAC to Services Portfolio 2Health News:OrthoSynetics(TM) Adds ORTHOTRAC to Services Portfolio 3Health News:Penn Pharma Invests In World-Class Inventory Management System 2
Ideal for lower abdominal procedures. Comes with a left side separating zipper....
Female High Waist Briefs...
Provides upper and lower arm support. Extends to the lower arm and across the shoulders. Has two columns of hook & eye closure for added adjustability....
Provides upper and lower arm and flank support. Extends to the wrist and over the full upper back. Has a thin strap above the breast and a 3 waistband for a secure, comfortable fit. Made of soft span...
Medicine Products: